Selvita Reports Second Quarter and Half-Year 2019 Financial Results

Krakow, Poland – 5 September 2019 – Selvita (WSE:SLV) today reported second quarter 2019 financial results and provided a corporate update. “We continue to execute on the priorities we set out early in the year,” commented Pawel Przewiezlikowski, Chief Executive Officer of Selvita. “We expect to see our oncology therapeutics…

More

Selvita to Present at Upcoming Conferences in September

Krakow, Poland – 3 September 2019 – Selvita (WSE: SLV) today announced that Pawel Przewiezlikowski, Chief Executive Officer, will present at the following conferences in New York:   Event: H.C. Wainwright 21st Annual Global Investment Conference, Sept. 8-10, 2019 Location: Lotte New York Palace Hotel Date/Time: Monday, Sept. 9, at…

More

Selvita and Sandoz chemists’ research published in Heterocycles

Krakow, Poland – 20 August 2019 – Selvita and Sandoz researchers have recently jointly published an article: Mini-Review: The Chemistry of Vorapaxar – Is There Any Room for Improvement Left?, which appeared in the Heterocycles, an International Journal for Reviews and Communications in Heterocyclic Chemistry, published online by The Japan Institute…

More

12345...1020...